iGMDRD549
Canonical SMILES: C=CC(=O)N1CCCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N
InChI: InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1
InChI Key: XYFPWWZEPKGCCK-GOSISDBHSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | DRUGBANK ID | Drug Status | Drug Type |
---|---|---|---|---|---|
Standard NameIbrutinib (PCI-32765) CHEMBLCHEMBL1873475 Pubchem CID24821100 DRUGBANK IDDB09053 Drug StatusAlone Drug TypeSmall Molecule |
Drug Class:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsAzolesCYP3A Substrates (Sensitive)Cytochrome P-450 CYP1A2 SubstratesCytochrome P-450 CYP3A SubstratesHeterocyclic CompoundsHeterocyclic Compounds, 1-RingImmunosuppressive AgentsKinase InhibitorMyelosuppressive AgentsProtein Kinase InhibitorsDrug Targets:
BTK (Q06187)Drug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Ibrutinib (PCI-32765)
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |